BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33539249)

  • 1. Predicting postoperative liver cancer death outcomes with machine learning.
    Wang Y; Ji C; Wang Y; Ji M; Yang JJ; Zhou CM
    Curr Med Res Opin; 2021 Apr; 37(4):629-634. PubMed ID: 33539249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Learning Can Predict Total Death After Radiofrequency Ablation in Liver Cancer Patients.
    Tong J; Liu P; Ji M; Wang Y; Xue Q; Yang JJ; Zhou CM
    Clin Med Insights Oncol; 2021; 15():11795549211000017. PubMed ID: 33854400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning.
    Zhou C; Wang Y; Ji MH; Tong J; Yang JJ; Xia H
    Cancer Control; 2020; 27(1):1073274820968900. PubMed ID: 33115287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting postoperative delirium after microvascular decompression surgery with machine learning.
    Wang Y; Lei L; Ji M; Tong J; Zhou CM; Yang JJ
    J Clin Anesth; 2020 Nov; 66():109896. PubMed ID: 32504969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning to predict the cancer-specific mortality of patients with primary non-metastatic invasive breast cancer.
    Zhou CM; Xue Q; Wang Y; Tong J; Ji M; Yang JJ
    Surg Today; 2021 May; 51(5):756-763. PubMed ID: 33104877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A machine learning-based predictor for the identification of the recurrence of patients with gastric cancer after operation.
    Zhou C; Hu J; Wang Y; Ji MH; Tong J; Yang JJ; Xia H
    Sci Rep; 2021 Jan; 11(1):1571. PubMed ID: 33452440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting postoperative gastric cancer prognosis based on inflammatory factors and machine learning technology.
    Zhou CM; Wang Y; Yang JJ; Zhu Y
    BMC Med Inform Decis Mak; 2023 Mar; 23(1):53. PubMed ID: 37004065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning Algorithms for Predicting the Recurrence of Stage IV Colorectal Cancer After Tumor Resection.
    Xu Y; Ju L; Tong J; Zhou CM; Yang JJ
    Sci Rep; 2020 Feb; 10(1):2519. PubMed ID: 32054897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervised Machine Learning Predictive Analytics For Triple-Negative Breast Cancer Death Outcomes.
    Xu Y; Ju L; Tong J; Zhou C; Yang J
    Onco Targets Ther; 2019; 12():9059-9067. PubMed ID: 31802913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of machine learning algorithms for predicting acute kidney injury after liver cancer resection.
    Lei L; Wang Y; Xue Q; Tong J; Zhou CM; Yang JJ
    PeerJ; 2020; 8():e8583. PubMed ID: 32140301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning algorithms based on proteomic data mining accurately predicting the recurrence of hepatitis B-related hepatocellular carcinoma.
    Feng G; He N; Xia HH; Mi M; Wang K; Byrne CD; Targher G; Yuan HY; Zhang XL; Zheng MH; Ye F
    J Gastroenterol Hepatol; 2022 Nov; 37(11):2145-2153. PubMed ID: 35816347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing Machine Learning Algorithms to Predict Pulmonary Complications After Emergency Gastrointestinal Surgery.
    Xue Q; Wen D; Ji MH; Tong J; Yang JJ; Zhou CM
    Front Med (Lausanne); 2021; 8():655686. PubMed ID: 34409047
    [No Abstract]   [Full Text] [Related]  

  • 14. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
    Luo H; Li C; Chen L
    Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning Prediction Models for Diagnosing Hepatocellular Carcinoma with HCV-related Chronic Liver Disease.
    Hashem S; ElHefnawi M; Habashy S; El-Adawy M; Esmat G; Elakel W; Abdelazziz AO; Nabeel MM; Abdelmaksoud AH; Elbaz TM; Shousha HI
    Comput Methods Programs Biomed; 2020 Nov; 196():105551. PubMed ID: 32580053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study.
    Huang C; Fang M; Feng H; Liu L; Li Y; Xu X; Wang H; Wang Y; Tong L; Zhou L; Gao C
    Int J Cancer; 2021 Aug; 149(3):717-727. PubMed ID: 33729545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification and Prognosis Prediction from Histopathological Images of Hepatocellular Carcinoma by a Fully Automated Pipeline Based on Machine Learning.
    Liao H; Xiong T; Peng J; Xu L; Liao M; Zhang Z; Wu Z; Yuan K; Zeng Y
    Ann Surg Oncol; 2020 Jul; 27(7):2359-2369. PubMed ID: 31916093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
    Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
    Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
    Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Farooq A; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Mar; 27(3):866-874. PubMed ID: 31696396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.